Cerebrovascular stenosis related to tyrosine kinase inhibitor for chronic myeloid leukemia: two illustrative cases

Cerebrovascular stenosis related to tyrosine kinase inhibitor for chronic myeloid leukemia: two illustrative cases

Abstract Background Tyrosine kinase inhibitors (TKIs) improve prognosis in chronic myeloid leukemia (CML). Nilotinib and ponatinib, second- and third-generation TKIs, respectively, have been reported to cause adverse vascular occlusive events such as myocardial infarction and peripheral arterial dis...

Full description

Saved in:
Bibliographic Details
Main Authors: Nozomi Sasaki, Yukiko Enomoto, Takamitsu Hori, Hirofumi Matsubara, Yusuke Egashira, Tsuyoshi Izumo
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Neurology
Subjects:
Cerebrovascular stenosis
Tyrosine kinase inhibitor
Chronic myeloid leukemia
Vascular endothelial cell
Online Access:https://doi.org/10.1186/s12883-024-04006-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items